Pre-order Enquiry
Request Free Sample
Global Opioids Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-15956103 | Publishing Date : 23-Jul-2020 | No. of pages : 116
Detailed TOC of Global Opioids Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Opioids Drug Market Overview1.1 Opioids Drug Product Overview
1.2 Opioids Drug Market Segment by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Global Opioids Drug Market Size by Type (2015-2026)
1.3.1 Global Opioids Drug Market Size Overview by Type (2015-2026)
1.3.2 Global Opioids Drug Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Opioids Drug Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Opioids Drug Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Opioids Drug Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Opioids Drug Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Opioids Drug Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Opioids Drug Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Opioids Drug Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Opioids Drug Sales Breakdown by Type (2015-2026)
1.4.2 Europe Opioids Drug Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Opioids Drug Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Opioids Drug Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Opioids Drug Sales Breakdown by Type (2015-2026)
2 Global Opioids Drug Market Competition by Company
2.1 Global Top Players by Opioids Drug Sales (2015-2020)
2.2 Global Top Players by Opioids Drug Revenue (2015-2020)
2.3 Global Top Players Opioids Drug Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Opioids Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioids Drug Market Competitive Situation and Trends
2.5.1 Opioids Drug Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioids Drug Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2019)
2.7 Date of Key Manufacturers Enter into Opioids Drug Market
2.8 Key Manufacturers Opioids Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Opioids Drug Status and Outlook by Region (2015-2026)
3.1 Global Opioids Drug Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Opioids Drug Market Size Market Share by Region (2015-2020)
3.2.1 Global Opioids Drug Sales Market Share by Region (2015-2020)
3.2.2 Global Opioids Drug Revenue Market Share by Region (2015-2020)
3.2.3 Global Opioids Drug Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Opioids Drug Market Size Market Share by Region (2021-2026)
3.3.1 Global Opioids Drug Sales Market Share by Region (2021-2026)
3.3.2 Global Opioids Drug Revenue Market Share by Region (2021-2026)
3.3.3 Global Opioids Drug Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Opioids Drug Market Size YoY Growth (2015-2026)
3.4.1 North America Opioids Drug Revenue YoY Growth (2015-2026)
3.4.2 North America Opioids Drug Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Opioids Drug Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Opioids Drug Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Opioids Drug Sales YoY Growth (2015-2026)
3.6 Europe Opioids Drug Market Size YoY Growth (2015-2026)
3.6.1 Europe Opioids Drug Revenue YoY Growth (2015-2026)
3.6.2 Europe Opioids Drug Sales YoY Growth (2015-2026)
3.7 Latin America Opioids Drug Market Size YoY Growth (2015-2026)
3.7.1 Latin America Opioids Drug Revenue YoY Growth (2015-2026)
3.7.2 Latin America Opioids Drug Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Opioids Drug Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Opioids Drug Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Opioids Drug Sales YoY Growth (2015-2026)
4 Global Opioids Drug by Application
4.1 Opioids Drug Segment by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Other
4.2 Global Opioids Drug Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Opioids Drug Historic Sales by Application (2015-2020)
4.4 Global Opioids Drug Forecasted Sales by Application (2021-2026)
4.5 Key Regions Opioids Drug Market Size by Application
4.5.1 North America Opioids Drug by Application
4.5.2 Europe Opioids Drug by Application
4.5.3 Asia-Pacific Opioids Drug by Application
4.5.4 Latin America Opioids Drug by Application
4.5.5 Middle East and Africa Opioids Drug by Application
5 North America Opioids Drug Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Opioids Drug Sales Market Share by Country (2015-2020)
5.1.2 North America Opioids Drug Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Opioids Drug Sales Market Share by Country (2021-2026)
5.2.2 North America Opioids Drug Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Opioids Drug Market Size YoY Growth (2015-2026)
5.3.2 Canada Opioids Drug Market Size YoY Growth (2015-2026)
6 Europe Opioids Drug Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Opioids Drug Sales Market Share by Country (2015-2020)
6.1.2 Europe Opioids Drug Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Opioids Drug Sales Market Share by Country (2021-2026)
6.2.2 Europe Opioids Drug Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Opioids Drug Market Size YoY Growth (2015-2026)
6.3.2 France Opioids Drug Market Size YoY Growth (2015-2026)
6.3.3 U.K. Opioids Drug Market Size YoY Growth (2015-2026)
6.3.4 Italy Opioids Drug Market Size YoY Growth (2015-2026)
6.3.5 Russia Opioids Drug Market Size YoY Growth (2015-2026)
7 Asia-Pacific Opioids Drug Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Opioids Drug Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Opioids Drug Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Opioids Drug Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Opioids Drug Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Opioids Drug Market Size YoY Growth (2015-2026)
7.3.2 Japan Opioids Drug Market Size YoY Growth (2015-2026)
7.3.3 South Korea Opioids Drug Market Size YoY Growth (2015-2026)
7.3.4 India Opioids Drug Market Size YoY Growth (2015-2026)
7.3.5 Australia Opioids Drug Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Opioids Drug Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Opioids Drug Market Size YoY Growth (2015-2026)
7.3.8 Thailand Opioids Drug Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Opioids Drug Market Size YoY Growth (2015-2026)
7.3.10 Philippines Opioids Drug Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Opioids Drug Market Size YoY Growth (2015-2026)
8 Latin America Opioids Drug Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Opioids Drug Sales Market Share by Country (2015-2020)
8.1.2 Latin America Opioids Drug Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Opioids Drug Sales Market Share by Country (2021-2026)
8.2.2 Latin America Opioids Drug Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Opioids Drug Market Size YoY Growth (2015-2026)
8.3.2 Brazil Opioids Drug Market Size YoY Growth (2015-2026)
8.3.3 Argentina Opioids Drug Market Size YoY Growth (2015-2026)
9 Middle East and Africa Opioids Drug Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Opioids Drug Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Opioids Drug Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Opioids Drug Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Opioids Drug Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Opioids Drug Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Opioids Drug Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Opioids Drug Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Opioids Drug Business
10.1 Teva
10.1.1 Teva Corporation Information
10.1.2 Teva Description, Business Overview and Total Revenue
10.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Teva Opioids Drug Products Offered
10.1.5 Teva Recent Development
10.2 Purdue Pharma
10.2.1 Purdue Pharma Corporation Information
10.2.2 Purdue Pharma Description, Business Overview and Total Revenue
10.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.2.4 Teva Opioids Drug Products Offered
10.2.5 Purdue Pharma Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Corporation Information
10.3.2 Mallinckrodt Description, Business Overview and Total Revenue
10.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Mallinckrodt Opioids Drug Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Amneal Pharma
10.4.1 Amneal Pharma Corporation Information
10.4.2 Amneal Pharma Description, Business Overview and Total Revenue
10.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Amneal Pharma Opioids Drug Products Offered
10.4.5 Amneal Pharma Recent Development
10.5 Collegium
10.5.1 Collegium Corporation Information
10.5.2 Collegium Description, Business Overview and Total Revenue
10.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Collegium Opioids Drug Products Offered
10.5.5 Collegium Recent Development
10.6 J&J
10.6.1 J&J Corporation Information
10.6.2 J&J Description, Business Overview and Total Revenue
10.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.6.4 J&J Opioids Drug Products Offered
10.6.5 J&J Recent Development
10.7 Endo
10.7.1 Endo Corporation Information
10.7.2 Endo Description, Business Overview and Total Revenue
10.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.7.4 Endo Opioids Drug Products Offered
10.7.5 Endo Recent Development
10.8 Pfizer
10.8.1 Pfizer Corporation Information
10.8.2 Pfizer Description, Business Overview and Total Revenue
10.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.8.4 Pfizer Opioids Drug Products Offered
10.8.5 Pfizer Recent Development
10.9 INSYS
10.9.1 INSYS Corporation Information
10.9.2 INSYS Description, Business Overview and Total Revenue
10.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.9.4 INSYS Opioids Drug Products Offered
10.9.5 INSYS Recent Development
10.10 Mylan
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioids Drug Product Category, Application and Specification
10.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 Mylan Recent Development
10.11 Hikma
10.11.1 Hikma Corporation Information
10.11.2 Hikma Description, Business Overview and Total Revenue
10.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.11.4 Hikma Opioids Drug Products Offered
10.11.5 Hikma Recent Development
10.12 Egalet
10.12.1 Egalet Corporation Information
10.12.2 Egalet Description, Business Overview and Total Revenue
10.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
10.12.4 Egalet Opioids Drug Products Offered
10.12.5 Egalet Recent Development
11 Opioids Drug Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioids Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioids Drug Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
List of Figures, Tables and Charts Available in Global Opioids Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Players of Oxycodone
Table 2. Major Players of Hydromorphone
Table 3. Major Players of Codeine
Table 4. Major Players of Fentanyl
Table 5. Major Players of Other
Table 6. Global Opioids Drug Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million)
Table 7. Global Opioids Drug Sales (M Units) by Type (2015-2020) (M Units)
Table 8. Global Opioids Drug Sales Share by Type (2015-2020)
Table 9. Global Opioids Drug Revenue (Million USD) by Type (2015-2020)
Table 10. Global Opioids Drug Revenue Share by Type (2015-2020)
Table 11. Global Opioids Drug Average Selling Price (ASP) (USD/Unit) by Type (2015-2020)
Table 12. Global Opioids Drug Sales by Type (2021-2026) (M Units)
Table 13. Global Opioids Drug Sales Share by Type (2021-2026)
Table 14. Global Opioids Drug Revenue (US$ Million) by Type (2021-2026)
Table 15. Global Opioids Drug Revenue Share by Type (2021-2026)
Table 16. Global Opioids Drug Average Selling Price (ASP) (USD/Unit) by Type (2021-2026)
Table 17. North America Opioids Drug Sales (USD/Unit) by Type (2015-2020)
Table 18. Europe Opioids Drug Sales (USD/Unit) by Type (2015-2020)
Table 19. Asia-Pacific Opioids Drug Sales (USD/Unit) by Type (2015-2020)
Table 20. Latin America Opioids Drug Sales (USD/Unit) by Type (2015-2020)
Table 21. Middle East and Africa Opioids Drug Sales (USD/Unit) by Type (2015-2020)
Table 22. Global Opioids Drug Sales (M Units) by Company (2015-2020)
Table 23. Global Opioids Drug Sales Share by Company (2015-2020)
Table 24. Global Opioids Drug Revenue (Million US$) by Company (2015-2020)
Table 25. Global Opioids Drug Revenue Share by Company (2015-2020)
Table 26. Global Market Opioids Drug Average Selling Price (USD/Unit) by Company (2015-2020)
Table 27. Global Opioids Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 28. Global Opioids Drug Top Manufacturers Product Category
Table 29. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2019
Table 31. Date of Key Manufacturers Enter into Opioids Drug Market
Table 32. Key Manufacturers Opioids Drug Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Opioids Drug Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026
Table 35. Global Opioids Drug Sales (M Units) by Region (2015-2020)
Table 36. Global Opioids Drug Sales Market Share by Region (2015-2020)
Table 37. Global Opioids Drug Revenue (US$ Million) by Region (2015-2020)
Table 38. Global Opioids Drug Revenue Market Share by Region (2015-2020)
Table 39. Global Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 40. Global Opioids Drug Sales (M Units) by Region (2021-2026)
Table 41. Global Opioids Drug Sales Market Share by Region (2021-2026)
Table 42. Global Opioids Drug Revenue (US$ Million) by Region (2021-2026)
Table 43. Global Opioids Drug Revenue Market Share by Region (2021-2026)
Table 44. Global Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 45. Global Opioids Drug Sales (M Units) by Application: 2015 VS 2020 VS 2026
Table 46. Global Opioids Drug Sales (M Units) by Application (2015-2020)
Table 47. Global Opioids Drug Sales Share by Application (2015-2020)
Table 48. Global Opioids Drug Sales (M Units) by Application (2021-2026)
Table 49. Global Opioids Drug Sales Share by Application (2021-2026)
Table 50. North America Opioids Drug Sales (M Units) by Application (2015-2020)
Table 51. North America Sales Opioids Drug Market Share by Application (2015-2020)
Table 52. Europe Opioids Drug Sales (M Units) by Application (2015-2020)
Table 53. Europe Sales Opioids Drug Market Share by Application In 2019
Table 54. Asia-Pacific Opioids Drug Sales (M Units) by Application (2015-2020)
Table 55. Asia-Pacific Sales Opioids Drug Market Share by Application In 2019
Table 56. Latin America Opioids Drug Sales (M Units) by Application (2015-2020)
Table 57. Latin America Sales Opioids Drug Market Share by Application In 2019
Table 58. Middle East and Africa Opioids Drug Sales (M Units) by Application (2015-2020)
Table 59. Middle East and Africa Opioids Drug Sales Share by Application (2015-2020)
Table 60. North America Opioids Drug Sales (M Units) by Country (2015-2020)
Table 61. North America Opioids Drug Sales Market Share by Country (2015-2020)
Table 62. North America Opioids Drug Revenue (US$ Million) by Country (2015-2020)
Table 63. North America Opioids Drug Revenue Market Share by Country (2015-2020)
Table 64. North America Opioids Drug Sales (M Units) by Country (2021-2026)
Table 65. North America Opioids Drug Sales Market Share by Country (2021-2026)
Table 66. North America Opioids Drug Revenue (US$ Million) by Country (2021-2026)
Table 67. North America Opioids Drug Revenue Market Share by Country (2021-2026)
Table 68. Europe Opioids Drug Sales (M Units) by Country (2015-2020)
Table 69. Europe Opioids Drug Sales Market Share by Country (2015-2020)
Table 70. Europe Opioids Drug Revenue (US$ Million) by Country (2015-2020)
Table 71. Europe Opioids Drug Revenue Market Share by Country (2015-2020)
Table 72. Europe Opioids Drug Sales (M Units) by Country (2021-2026)
Table 73. Europe Opioids Drug Sales Market Share by Country (2021-2026)
Table 74. Europe Opioids Drug Revenue (US$ Million) by Country (2021-2026)
Table 75. Europe Opioids Drug Revenue Market Share by Country (2021-2026)
Table 76. Asia-Pacific Opioids Drug Sales (M Units) by Region (2015-2020)
Table 77. Asia-Pacific Opioids Drug Sales Market Share by Region (2015-2020)
Table 78. Asia-Pacific Opioids Drug Revenue (US$ Million) by Region (2015-2020)
Table 79. Asia-Pacific Opioids Drug Revenue Market Share by Region (2015-2020)
Table 80. Asia-Pacific Opioids Drug Sales (M Units) by Region (2021-2026)
Table 81. Asia-Pacific Opioids Drug Sales Market Share by Region (2021-2026)
Table 82. Asia-Pacific Opioids Drug Revenue (US$ Million) by Region (2021-2026)
Table 83. Asia-Pacific Opioids Drug Revenue Market Share by Region (2021-2026)
Table 84. Latin America Opioids Drug Sales (M Units) by Country (2015-2020)
Table 85. Latin America Opioids Drug Sales Market Share by Country (2015-2020)
Table 86. Latin America Opioids Drug Revenue (US$ Million) by Country (2015-2020)
Table 87. Latin America Opioids Drug Revenue Market Share by Country (2015-2020)
Table 88. Latin America Opioids Drug Sales (M Units) by Country (2021-2026)
Table 89. Latin America Opioids Drug Sales Market Share by Country (2021-2026)
Table 90. Latin America Opioids Drug Revenue (US$ Million) by Country (2021-2026)
Table 91. Latin America Opioids Drug Revenue Market Share by Country (2021-2026)
Table 92. Middle East and Africa Opioids Drug Sales (M Units) by Country (2015-2020)
Table 93. Middle East and Africa Opioids Drug Sales Market Share by Country (2015-2020)
Table 94. Middle East and Africa Opioids Drug Revenue (US$ Million) by Country (2015-2020)
Table 95. Middle East and Africa Opioids Drug Revenue Market Share by Country (2015-2020)
Table 96. Middle East and Africa Opioids Drug Sales (M Units) by Country (2021-2026)
Table 97. Middle East and Africa Opioids Drug Sales Market Share by Country (2021-2026)
Table 98. Middle East and Africa Opioids Drug Revenue (US$ Million) by Country (2021-2026)
Table 99. Middle East and Africa Opioids Drug Revenue Market Share by Country (2021-2026)
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teva Opioids Drug Product
Table 104. Teva Recent Development
Table 105. Purdue Pharma Corporation Information
Table 106. Purdue Pharma Description and Business Overview
Table 107. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Purdue Pharma Opioids Drug Product
Table 109. Purdue Pharma Recent Development
Table 110. Mallinckrodt Corporation Information
Table 111. Mallinckrodt Description and Business Overview
Table 112. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Mallinckrodt Opioids Drug Product
Table 114. Mallinckrodt Recent Development
Table 115. Amneal Pharma Corporation Information
Table 116. Amneal Pharma Description and Business Overview
Table 117. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Amneal Pharma Opioids Drug Product
Table 119. Amneal Pharma Recent Development
Table 120. Collegium Corporation Information
Table 121. Collegium Description and Business Overview
Table 122. Collegium Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Collegium Opioids Drug Product
Table 124. Collegium Recent Development
Table 125. J&J Corporation Information
Table 126. J&J Description and Business Overview
Table 127. J&J Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. J&J Opioids Drug Product
Table 129. J&J Recent Development
Table 130. Endo Corporation Information
Table 131. Endo Description and Business Overview
Table 132. Endo Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Endo Opioids Drug Product
Table 134. Endo Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Pfizer Opioids Drug Product
Table 139. Pfizer Recent Development
Table 140. INSYS Corporation Information
Table 141. INSYS Description and Business Overview
Table 142. INSYS Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. INSYS Opioids Drug Product
Table 144. INSYS Recent Development
Table 145. Mylan Corporation Information
Table 146. Mylan Description and Business Overview
Table 147. Mylan Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Mylan Opioids Drug Product
Table 149. Mylan Recent Development
Table 150. Hikma Corporation Information
Table 151. Hikma Description and Business Overview
Table 152. Hikma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Hikma Opioids Drug Product
Table 154. Hikma Recent Development
Table 155. Egalet Corporation Information
Table 156. Egalet Description and Business Overview
Table 157. Egalet Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Egalet Opioids Drug Product
Table 159. Egalet Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 163. Key Challenges
Table 164. Market Risks
Table 165. Distributors List
Table 166. Opioids Drug Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Revenue (Million USD) Status and Outlook (2015-2026)
Figure 3. Global Opioids Drug Sales (M Units) Status and Outlook (2015-2026)
Figure 4. Product Picture of Oxycodone
Figure 5. Global Oxycodone Sales (M Units) and Growth Rate (2015-2020)
Figure 6. Product Picture of Hydromorphone
Figure 7. Global Hydromorphone Sales (M Units) and Growth Rate (2015-2020)
Figure 8. Product Picture of Codeine
Figure 9. Global Codeine Sales (M Units) and Growth Rate (2015-2020)
Figure 10. Product Picture of Fentanyl
Figure 11. Global Fentanyl Sales (M Units) and Growth Rate (2015-2020)
Figure 12. Product Picture of Other
Figure 13. Global Other Sales (M Units) and Growth Rate (2015-2020)
Figure 14. Global Opioids Drug Revenue and Growth Rate by Type (US$ Million)
Figure 15. Global Opioids Drug Sales Market Share by Type (2015-2020)
Figure 16. Global Opioids Drug Sales Market Share by Type in 2019
Figure 17. Global Opioids Drug Revenue Share by Type (2015-2020)
Figure 18. Global Opioids Drug Revenue Market Share by Type in 2019
Figure 19. Global Opioids Drug Sales Market Share by Type (2021-2026)
Figure 20. Global Opioids Drug Sales Market Share by Type In 2019
Figure 21. Global Opioids Drug Revenue Share by Type (2021-2026)
Figure 22. Global Opioids Drug Revenue Market Share by Type In 2019
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Drug Sales in 2019
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Drug Revenue in 2019
Figure 25. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. North America Opioids Drug Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 27. North America Opioids Drug Sales YoY Growth (2015-2026) (M Units)
Figure 28. Asia-Pacific Opioids Drug Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 29. Asia-Pacific Opioids Drug Sales YoY Growth (2015-2026) (M Units)
Figure 30. Europe Opioids Drug Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 31. Europe Opioids Drug Sales YoY Growth (2015-2026) (M Units)
Figure 32. Latin America Opioids Drug Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 33. Latin America Opioids Drug Sales YoY Growth (2015-2026) (M Units)
Figure 34. Middle East and Africa Opioids Drug Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 35. Middle East and Africa Opioids Drug Sales YoY Growth (2015-2026) (M Units)
Figure 36. Pain Relief Examples
Figure 37. Anesthesia Examples
Figure 38. Other Examples
Figure 39. U.S. Opioids Drug Sales (M Units) (2015-2026)
Figure 40. U.S. Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 41. Canada Opioids Drug Sales (M Units) (2015-2026)
Figure 42. Canada Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 43. Germany Opioids Drug Sales (M Units) (2015-2026)
Figure 44. Germany Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 45. France Opioids Drug Sales (M Units) (2015-2026)
Figure 46. France Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 47. U.K. Opioids Drug Sales (M Units) (2015-2026)
Figure 48. U.K. Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 49. Italy Opioids Drug Sales (M Units) (2015-2026)
Figure 50. Italy Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 51. Russia Opioids Drug Sales (M Units) (2015-2026)
Figure 52. Russia Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 53. China Opioids Drug Sales (M Units) (2015-2026)
Figure 54. China Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 55. Japan Opioids Drug Sales (M Units) (2015-2026)
Figure 56. Japan Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 57. South Korea Opioids Drug Sales (M Units) (2015-2026)
Figure 58. South Korea Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 59. India Opioids Drug Sales (M Units) (2015-2026)
Figure 60. India Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 61. Australia Opioids Drug Sales (M Units) (2015-2026)
Figure 62. Australia Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 63. Taiwan Opioids Drug Sales (M Units) (2015-2026)
Figure 64. Taiwan Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 65. Indonesia Opioids Drug Sales (M Units) (2015-2026)
Figure 66. Indonesia Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 67. Thailand Opioids Drug Sales (M Units) (2015-2026)
Figure 68. Thailand Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 69. Malaysia Opioids Drug Sales (M Units) (2015-2026)
Figure 70. Malaysia Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 71. Philippines Opioids Drug Sales (M Units) (2015-2026)
Figure 72. Philippines Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 73. Vietnam Opioids Drug Sales (M Units) (2015-2026)
Figure 74. Vietnam Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 75. Mexico Opioids Drug Sales (M Units) (2015-2026)
Figure 76. Mexico Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 77. Brazil Opioids Drug Sales (M Units) (2015-2026)
Figure 78. Brazil Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 79. Argentina Opioids Drug Sales (M Units) (2015-2026)
Figure 80. Argentina Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 81. Turkey Opioids Drug Sales (M Units) (2015-2026)
Figure 82. Turkey Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 83. Saudi Arabia Opioids Drug Sales (M Units) (2015-2026)
Figure 84. Saudi Arabia Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 85. U.A.E Opioids Drug Sales (M Units) (2015-2026)
Figure 86. U.A.E Opioids Drug Revenue (US$ Million) (2015-2026)
Figure 87. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Amneal Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Collegium Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. J&J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. INSYS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Egalet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Key Raw Materials Price
Figure 100. Opioids Drug Manufacturing Cost Structure
Figure 101. Opioids Drug Industrial Chain Analysis
Figure 102. Porter's Five Forces Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
Keyplayers in Global Opioids Drug Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
TevaPurdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Request Sample
Request Discount
